Fluid removal and sleep apnea changes in heart failure patients
Official title: The Impact of Volume Overload on Obstructive Sleep Apnea in Patients With Congestive Heart Failure
Run by Shaare Zedek Medical Center · NCT07601724 · Data updated 2026-11-12
This study tests whether removing excess fluid in adults with heart failure improves their sleep apnea while in the hospital.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | Shaare Zedek Medical Center Academic / other |
| Locations | 1 site (Jerusalem) |
| Status | Recruiting |
| Started | January 1, 2026 |
| Main results expected | January 2027 |
| Study ends | June 2027 |
| Registry record updated | May 22, 2026 |
| Trial ID | NCT07601724 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18 years or older hospitalized for decompensated heart failure with fluid overload and able to undergo WatchPAT sleep assessment and provide consent.
✕Probably not a fit
Patients with central sleep apnea, those already on CPAP, or those unable to use the WatchPAT device may not experience sleep apnea benefit from the study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study follows adults hospitalized with decompensated heart failure and fluid overload to see how diuresis affects obstructive sleep apnea measured with a WatchPAT device. Sleep apnea is assessed before and after fluid removal, with neck circumference, weight, and fluid balance recorded. The study also uses routine clinical data to explore potential relationships between fluid changes and sleep-disordered breathing. Findings may clarify whether fluid management influences sleep apnea severity in this patient population.
Why it matters
Potential benefit: If successful, results could inform fluid-management strategies to help mild-to-moderate sleep apnea in heart failure patients.
How similar studies have gone: Previous research in related areas suggests fluid status can influence sleep-disordered breathing, but this specific diuresis-sleep apnea relationship in hospitalized heart failure patients is not well established.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults aged 18 years or older * Hospitalized with decompensated heart failure and clinical evidence of fluid overload * Diagnosis of heart failure (reduced or preserved ejection fraction) * Clinically indicated for diuretic therapy * Able to undergo sleep apnea assessment using the WatchPAT device * Able to provide informed consent Exclusion Criteria: * Known central sleep apnea as the predominant sleep-disordered breathing type * Current treatment with continuous positive airway pressure (CPAP) * Acute respiratory failure requiring mechanical ventilation * Conditions preventing proper use of the WatchPAT device (e.g., severe hand or finger injury) * Hemodynamic instability precluding participation * Pregnancy
Where it's running
-
Shaare Zedek Medical Center
Jerusalem, Israel Recruiting
Study contacts
- Study coordinator: Itshak Amsalem, MD
- Email: itshak1a@gmail.com
- Phone: +972508229454
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using Apple Watch data to predict heart failure outcomes
This study is testing if data from Apple Watches can help predict heart failure problems and the chances of needing to go back to the hospital for patients with heart failure.
-
Comparing Aortix Device to Diuretics for Acute Heart Failure
This study is testing whether the Aortix device can help people with acute heart failure who aren't responding to diuretics feel better compared to standard treatment.
-
Myocardial Energetics Across Cardiovascular Disease Spectrum Using 31P-MRS
Researchers are testing whether phosphorus-31 magnetic resonance spectroscopy (31P-MRS) can map heart energy metabolism across healthy people and patients with various heart conditions.
-
Tailored digital support to cut sedentary time in long-term cardiac rehab
In adults in a long-term cardiac rehabilitation program, this study tests whether a personalized behavioural program with digital tools can reduce daily sitting time.
-
NT-proBNP–guided heart failure screening for people 65+ in rural China
This study tests whether using NT-proBNP blood tests to guide heart failure screening in adults 65 and older in rural China can find unrecognized heart problems more effectively than symptom-based screening.
-
Voice-based detection of heart failure deterioration using Noah Labs Vox
This study tests whether a voice-analysis app can flag worsening heart failure in adults by comparing its alerts to standard weight-based monitoring.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.